Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prelude Therapeutics (PRLD) Cash from Operations (2024 - 2026)

Prelude Therapeutics' Cash from Operations history spans 3 years, with the latest figure at 21685000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations rose 36.65% to 21685000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 43756000.0, a 58.46% increase, with the full-year FY2025 number at 56302000.0, up 45.28% from a year prior.
  • Cash from Operations hit 21685000.0 in Q1 2026 for Prelude Therapeutics, down from 23119000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for PRLD hit a ceiling of 23119000.0 in Q4 2025 and a floor of 34231000.0 in Q1 2025.
  • Historically, Cash from Operations has averaged 20097222.22 across 3 years, with a median of 23057000.0 in 2024.
  • The widest YoY moves for Cash from Operations: up 211.45% in 2025, down 13.09% in 2025.
  • Tracing PRLD's Cash from Operations over 3 years: stood at 20744000.0 in 2024, then skyrocketed by 211.45% to 23119000.0 in 2025, then plummeted by 193.8% to 21685000.0 in 2026.
  • Business Quant data shows Cash from Operations for PRLD at 21685000.0 in Q1 2026, 23119000.0 in Q4 2025, and 19115000.0 in Q3 2025.